文献速递临床试验与 GCP

构建情绪觉察与心理健康(BEAM):针对18-36月龄儿童母亲的BEAM应用程序III期随机对照试验研究方案

Building Emotional Awareness and Mental Health (BEAM): study protocol for a phase III randomized controlled trial of the BEAM app-based program for mothers of children 18-36 months.
PubMed 文献 · Trials · 2022-09-05

该III期随机对照试验计划纳入140名自报中度至重度抑郁和/或焦虑症状、孩子年龄18至36个月的母亲,在线招募并随机分为BEAM应用程序干预组(10周心理教育模块、在线社会支持论坛和每周团体远程治疗)与常规治疗组,评估BEAM降低母亲抑郁症状(主要结局)及改善焦虑症状、育儿压力、家庭关系、母子功能(次要结局)的效果。

要点

  • BEAM为基于应用程序的干预,包含10周心理教育模块、在线社会支持论坛和每周团体远程治疗。
  • 研究纳入140名孩子18至36个月、自报中度至重度抑郁和/或焦虑症状的母亲。
  • 主要结局为母亲抑郁症状,次要结局包括焦虑症状、育儿压力、家庭关系和母子功能。

核心结论

  • 该试验旨在评估BEAM应用程序项目相比常规治疗在降低母亲抑郁症状(主要结局)及改善焦虑症状、育儿压力、家庭关系和母子功能(次要结局)方面的疗效。

研究设计与样本

  • 一项两臂重复测量随机对照试验,计划纳入140名孩子年龄18至36个月、自报中度至重度抑郁和/或焦虑症状的母亲。
  • 参与者在线招募,随机分配到治疗组者接受10周心理教育模块、在线社会支持论坛和每周团体远程治疗。
  • 评估时间点:产后18-36个月(测试前,T1)、BEAM干预最后一周后即刻(测试后,T2)和干预后3个月(随访,T3)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of maternal depression and anxiety has increased during the COVID-19 pandemic, and pregnant individuals are experiencing concerningly elevated levels of mental health symptoms worldwide. Many individuals may now be at heightened risk of postpartum mental health disorders. There are significant concerns that a cohort of children may be at-risk for impaired self-regulation and mental illness due to elevated exposure to perinatal mental illness. With both an increased prevalence of depression and limited availability of services due to the pandemic, there is an urgent need for accessible eHealth interventions for mothers of young children. The aims of this trial are to evaluate the efficacy of the Building Emotion Awareness and Mental Health (BEAM) app-based program for reducing maternal depression symptoms (primary outcome) and improve anxiety symptoms, parenting stress, family relationships, and mother and child functioning (secondary outcomes) compared to treatment as usual (TAU). METHODS: A two-arm randomized controlled trial (RCT) with repeated measures will be used to evaluate the efficacy of the BEAM intervention compared to TAU among a sample of 140 mothers with children aged 18 to 36 months, who self-report moderate-to-severe symptoms of depression and/or anxiety. Individuals will be recruited online, and those randomized to the treatment group will participate in 10 weeks of psychoeducation modules, an online social support forum, and weekly group teletherapy sessions. Assessments will occur at 18-36 months postpartum (pre-test, T1), immediately after the last week of the BEAM intervention (post-test, T2), and at 3 months after the intervention (follow-up, T3). DISCUSSION: eHealth interventions have the potential to address elevated maternal mental health symptoms, parenting stress, and child functioning concerns during and after the COVID-19 pandemic and to provide accessible programming to mothers who are in need of support. This RCT will build on an open pilot trial of the BEAM program and provide further evaluation of this evidence-based intervention. Findings will increase our understanding of depression in mothers with young children and reveal the potential for long-term improvements in maternal and child health and family well-being. TRIAL REGISTRATION: ClinicalTrials.gov NCT05306626 . Registered on April 1, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xie EB, Simpson KM, Reynolds KA, et al. Building Emotional Awareness and Mental Health (BEAM): study protocol for a phase III randomized controlled trial of the BEAM app-based program for mothers of children 18-36 months. Trials. 2022. PMID: 36064436. doi:10.1186/s13063-022-06512-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。